Formulary Watch Spotlights
Product Profile: LYNOZYFIC (linvoseltamab-gc)
Product Profile: LIBTAYO (cemiplimab)
Product Profile: JASCAYD (nerandomilast)
Product Profile: JOURNAVX (suzetrigine)
Product Profile: MONJUVI (tafasitamab-cxix injection, for intravenous use)
Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)
Product Profile: REXULTI (brexpiprazole tablet)
Product Profile: MIEBO (perfluorohexyloctane ophthalmic solution)
Product Profile: EYELEA HD (aflibercept injection, solution)
Product Profile: TARPEYO (budesonide capsule, delayed release)
Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Product Profile: XDEMVY (lotilaner ophthalmic solution)
Product Profile: ABILIFY ASIMTUFII (aripiprazole injection, suspension, extended release)
Product Profile: AREXVY (respiratory syncytial virus vaccine, adjuvanted)
Product Profile: ABRYSVO (respiratory syncytial virus vaccine)
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
5 things you should know about the midterms and healthcare
2
Prime's Pat Gleason flags cost, timing gaps in type 1 diabetes screening | AMCP Nexus 2026
3
Narcolepsy type 1 drives 5-fold higher costs in first year after diagnosis
4
5 things you should know about intismeran, the Moderna-Merck cancer vaccine
5